Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06845085
NA

Re-ablation of Persistent Atrial Fibrillation

Sponsor: Aarhus University Hospital

View on ClinicalTrials.gov

Summary

Pulmonary vein re-isolation plus Vein of Marshall ethanol ablation in combination with block of mitral and tricuspid isthmuses and dome line will be compared to pulmonary vein re-isolation alone in patients undergoing re-ablation for persistent atrial fibrillation in this investigator initiated, randomized, patient-assessor blinded multicenter trial. Patients are followed with standard ECG at 3 months, with standard ECG, 5-days' ECG monitoring and quality of life assessment after 12 months, with standard ECG and quality of life assessment after 24 months, through patient files at 60 months after the ablation. Primary endpoint: Change in AFEQT score between baseline and 12 months.

Official title: Re-ablation of Persistent Atrial Fibrillation: a Randomized Study, Evaluating Vein of Marshall Ethanol Ablation in Combination With Block of Mitral and Tricuspid Isthmuses and Dome Line

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

180

Start Date

2025-03

Completion Date

2032-10

Last Updated

2025-02-28

Healthy Volunteers

No

Interventions

PROCEDURE

Intervention

pulmonary vein re-isolation plus Vein of Marshall ethanol ablation in combination with block of mitral and tricuspid isthmuses and dome line

PROCEDURE

Control

pulmonary vein re-isolation

Locations (3)

Department of Cardiology, Aarhus University Hospital

Århus N, Danmark, Denmark

Department of Cardiology, Leiden University Medical Center

Leiden, Netherlands

Department of Cardiology, Karolinska University Hospital, Stockholm

Stockholm, Sweden